Researchers at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME), under the leadership of Assistant Professor Po-Chun Hsu, in close collaboration with Duke University’s engineering and medical teams, have unveiled a novel approach that boosts the efficacy of laser lithotripsy without necessitating modifications to the current laser technologies. Their breakthrough hinges on innovatively engineering the environment around the stone—specifically, the saline solution used during the procedure—to improve laser energy absorption and precision. Their findings, published in the journal Advanced Science, herald potential paradigm shifts in kidney stone management, promising reduced surgical durations, expedited recovery phases, and decline in recurrence rates.

Laser lithotripsy predominantly relies on holmium:yttrium-aluminum-garnet (Ho-YAG) lasers, which currently represent the gold standard in stone ablation. These lasers emit infrared light around a wavelength of 2,000 nanometers, tailored to target calcified kidney stones. In the surgical setting, a mild saline solution irrigates the affected kidney area to distend the hollow spaces and sustain visibility. However, a significant portion of the laser’s energy disperses into this fluid, manifesting as unwanted heat dissipation and diminishing the effective energy transferred to the kidney stone itself.

The interdisciplinary team addressed this inefficiency by introducing nanoparticles into the saline—ingeniously designed nanomaterials capable of absorbing the laser’s specific wavelengths. Embedded within the fluid, these conducting polymer nanoparticles act as laser energy concentrators, minimizing reflective loss and energy diffusion. As a result, a substantially higher fraction of the laser’s power is directly harnessed to fragment the stone. This innovation not only enhances ablation efficiency but also mitigates the collateral thermal damage to renal tissue, preserving patient safety.

From a materials science perspective, selecting the appropriate nanoparticle characteristics was crucial. The particles needed to possess strong absorption properties matching the laser wavelength, excellent dispersibility in aqueous solutions, and, importantly, biocompatibility to ensure patient safety. The research team meticulously engineered the nanofluid, confirming through in vitro studies that their formula met these criteria. Toxicity assays demonstrated that even after prolonged exposure—far exceeding the typical timeframe of lithotripsy—living cells remained unharmed by the nanoparticle-infused saline, underscoring its clinical potential.

Quantitative results from laboratory experiments were particularly striking. The nanofluid-enhanced lithotripsy exhibited improvements in stone ablation efficiency ranging from 38% to an astounding 727% during spot-targeted treatment, and between 26% to 75% in scanning approaches. These enhancements could dramatically shorten intervention times; a procedure currently lasting approximately 30 minutes might be condensed to as little as 10 minutes. Such reductions not only minimize anesthesia exposure but also substantially decrease the accumulation of thermal energy in renal tissues, further safeguarding against heat-induced injury.

A notable aspect of this research is its versatility across different laser types. While this study specifically examined Ho-YAG lasers, other laser technologies employed in lithotripsy vary in wavelength and operational characteristics. Dr. Pei Zhong of Duke University, one of the study’s senior authors, emphasizes that nanofluid therapy holds promise to augment a wide range of lithotripsy lasers. Its capacity to enhance performance irrespective of stone composition or laser wavelength could democratize access, enabling community hospitals to achieve superior outcomes without investing in multiple costly laser systems.

Beyond engineering ingenuity, this collaboration exemplifies the profound impact of interdisciplinary research. Clinicians at Duke Health collaborated intimately with engineers specializing in nanomaterials and laser physics, fostering a fertile exchange of ideas. As Michael Lipkin, a Duke urologist and co-author, reflects, such partnerships are instrumental in translating fundamental scientific insights into practical medical innovations that directly benefit patients.

Looking ahead, the research team is poised to expand on their promising initial findings with further studies. These will assess how the nanofluid-enhanced approach performs against naturally occurring kidney stones of varying compositions, as well as its efficacy with other established laser systems. These forthcoming investigations will be pivotal in moving from preclinical validation toward widespread clinical adoption.

This breakthrough not only exemplifies a significant scientific achievement but also addresses a pressing healthcare burden. Kidney stone disease afflicts approximately 11% of the American population, contributing to substantial clinical workload and immense healthcare expenditure exceeding $2 billion annually in the United States alone. Technological advancements that enhance the safety, speed, and effectiveness of lithotripsy have profound implications for improving patient quality of life and reducing systemic costs.

In sum, this pioneering nanofluid technology represents an elegant solution whereby modifying the laser’s working environment—rather than the laser device itself—unlocks superior treatment outcomes. As this field evolves, the integration of materials science, engineering, and clinical medicine continues to demonstrate transformative potential in urology and beyond, exemplifying the power of scientific innovation in addressing complex medical challenges.

Subject of Research: Nanomaterial-enhanced laser lithotripsy for improved kidney stone ablation efficiency.

Article Title: Nanofluid-Enhanced Laser Lithotripsy Using Conducting Polymer Nanoparticles

News Publication Date: October 5, 2025

Web References:
https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202507714

References:
Fan et al., “Nanofluid-Enhanced Laser Lithotripsy Using Conducting Polymer Nanoparticles,” Advanced Science, 2025.

Image Credits: UChicago Pritzker School of Molecular Engineering / John Zich

Keywords: Nanomaterials, Surgical procedures, Laser lithotripsy, Kidney stones, Nanofluid, Biocompatible nanoparticles, Ho-YAG laser, Thermal protection, Medical innovation

Traditionally, PCNL procedures have relied on fluoroscopy, a form of X-ray imaging, to guide needle placement into the kidney. While effective, fluoroscopy exposes patients and surgeons to ionizing radiation and provides only a two-dimensional projection, potentially limiting spatial awareness during critical puncture and tract dilation phases. The current study challenges this paradigm by substituting fluoroscopic imaging with ultrasonography, a radiation-free modality, thereby significantly reducing radiation exposure without compromising procedural accuracy.

The heart of this technical innovation lies in the real-time, three-dimensional visualization of kidney anatomy afforded by ultrasonography. This imaging modality allows surgeons to identify the renal collecting system, surrounding vasculature, and stone burden simultaneously, enabling a tailored and safer approach to each puncture site. Coupled with a robotic platform designed specifically for urologic interventions, the system translates ultrasound data into precise mechanical movements, offering sub-millimetric control over needle insertion and instrument navigation.

Ultrasonographic-guided robotic-assisted PCNL introduces several operational advantages compared to conventional methods. The robotic assistance mitigates human hand tremor and fatigue, ensuring consistent trajectory and depth during needle advancement. Moreover, the integration of real-time ultrasound feedback with robotic manipulation facilitates immediate adjustment to anatomical variability, which is paramount given the complex three-dimensional structure of the kidney and its proximity to vital tissues.

This synergy of imaging and robotics is made possible by advanced algorithms that interpret ultrasound signals to reconstruct dynamic anatomical maps. These maps feed into an intelligent navigation system that provides haptic feedback and predictive modelling, guiding the surgeon’s hand and robotic actuators in unison. The result is an unprecedented level of precision, greatly diminishing the risk of hemorrhage or injury to adjacent organs, risks traditionally inherent in percutaneous renal access.

Crucially, the study demonstrates that this technology can be seamlessly incorporated into existing surgical workflows. Surgeons reported an intuitive interface that did not extend procedure time and, in some cases, reduced it, owing to more efficient puncture attempts and tract creation. This highlights the potential for widespread adoption and scalability, particularly in centers equipped with robotic surgical suites but seeking to minimize radiation exposure for patients and operating teams.

The implications of this advancement extend beyond the immediate clinical outcomes. Reduced radiation exposure aligns with global safety mandates and addresses cumulative occupational hazards faced by surgical teams performing frequent PCNL procedures. Furthermore, enhanced procedural accuracy may translate into improved patient recovery profiles, with lower complication rates and shorter hospital stays, ultimately reducing healthcare costs and improving patient satisfaction.

From a technical perspective, the robotic system’s capability to interpret ultrasonographic data involves complex image processing and machine learning techniques. These analytical methods facilitate the differentiation between tissue types, stone densities, and instrument positioning, optimizing decision-making during puncture and tract dilation. The hardware-software integration ensures seamless real-time responsiveness, critical for the dynamic environments encountered during surgery.

Moreover, the study underscores the importance of multidisciplinary collaboration, combining expertise in urology, radiology, robotics, and computer science. This convergence is the backbone of the innovation, ensuring that each component — from high-frequency ultrasound probes to robotic arms and control software — operates harmoniously to achieve clinical objectives safely.

Patient outcomes reported in the analysis are promising: operative success rates paralleled or exceeded those of traditional PCNL while complication rates decreased. Pain scores postoperatively were reduced, likely reflecting the minimally traumatic nature of precision-guided access. Such findings reinforce the notion that newer technologies can deliver not only equivalent efficacy but also enhanced patient experience.

The novel approach also reveals significant educational benefits. The integrated ultrasound-robotic interface offers augmented reality overlays and objective metrics that can expedite the learning curves for trainees. This potential democratizes access to complex procedures, enabling surgeons in training to gain confidence and competence within a controlled, feedback-rich environment.

Looking toward the future, the fusion of ultrasonography and robotic assistance in PCNL may catalyze further innovations across other percutaneous and endoscopic interventions. The principles of radiation avoidance, enhanced precision, and real-time imaging could be adapted to diverse procedures across various organ systems, broadening the impact of this technological advancement.

Despite its promise, the system presently faces challenges including the need for optimized ultrasonographic probes tailored to specific anatomical nuances and the continued refinement of software algorithms to handle a wider variety of anatomical variations and pathological presentations. Ongoing clinical trials aim to validate these early results and expand understanding of long-term outcomes and cost-effectiveness.

In conclusion, the introduction of ultrasonographic-guided robotic-assisted PCNL represents a significant milestone in urologic surgery. By addressing longstanding limitations related to radiation exposure and manual dexterity, it redefines the standards for minimally invasive kidney stone management. This innovation exemplifies how convergence of cutting-edge imaging and robotics can reshape surgical paradigms, underscoring the limitless potential of interdisciplinary technology in advancing patient care.

Subject of Research: Ultrasonographic guidance combined with robotic assistance in percutaneous nephrolithotomy for improved safety and precision in kidney stone removal.

Article Title: Ultrasonographic-guided robotic-assisted percutaneous nephrolithotomy.

Article References:

Bazzani, S., Puliatti, S., Ferretti, S. et al. Ultrasonographic-guided robotic-assisted percutaneous nephrolithotomy.
Commun Eng 4, 120 (2025). https://doi.org/10.1038/s44172-025-00451-0

Image Credits: AI Generated